Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Antiandrogen therapy helps treat genetic hair loss.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Cholesterol-modified siRNAs targeting certain genes increased hair growth in mice.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Exosomes from human fat stem cells can potentially enhance hair growth and survival, providing a new possible treatment for hair loss.

Increasing miR-149 reduces hair follicle stem cell growth and hair development by affecting certain cell growth pathways.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Terminalia bellirica extract may help promote hair growth and prevent hair loss caused by testosterone.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Exosomes from skin cells can boost hair growth by stimulating a gene called LEF1.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

New treatments for male hypogonadism are effective and should be personalized.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Red ginseng oil is believed to have various health benefits and is safe, but more research is needed to fully understand how it works.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.